AI assistant
Sending…
Krystal Biotech, Inc. — Director's Dealing 2017
Sep 20, 2017
31006_dirs_2017-09-19_45ccbad7-f498-423d-9901-dc469707626f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Krystal Biotech, Inc. (KRYS)
CIK: 0001711279
Period of Report: 2017-09-19
Reporting Person: NORBY R DOUGLAS (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $11.07 | 2026-11-29 | Common Stock (18949) | Direct |
Footnotes
F1: The options were awarded on November 30, 2016 and vest ratably over a four-year period.
More from Krystal Biotech, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Earnings Release
2026
May 4
Interim / Quarterly Report
2026
May 4
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4